https://www.selleckchem.com/products/s961.html
The AUCs of training and validation cohorts were 0.764 (95% CI 0.729-0.798) and 0.777 (95% CI 0.692-0.862), respectively. We presented a new prediction model with excellent clinical applicability and diagnostic performance for use by clinicians as an intraoperative clinical tool to predict risk of NSLN metastasis in Chinese breast cancer patients with 1-2 positive SLNs and make the final decisions regarding axillary lymph node dissection.The coronavirus disease 2019 (COVID-19) is the latest biological hazard for the novel severe acute resp
Beğen
Yorum Yap
Paylaş
